What QC Kinetix does

QC Kinetix is a Charlotte, North Carolina-based regenerative medicine franchise founded in 2017, operating as the largest regenerative medicine franchise in North America with more than 100 clinic locations across 30+ states. The company provides non-surgical, drug-free treatments for chronic joint pain, osteoarthritis, sports injuries, and musculoskeletal conditions, using orthobiologic protocols built on the patient's own biologics — Platelet-Rich Plasma (PRP) with a stated 10-billion platelet dosing standard, Bone Marrow Aspirate Concentrate (BMAC), Plasma Protein Concentrate (PPC/A2M), and Class IV laser therapy — typically deployed as a sequenced, multi-layered protocol under ultrasound guidance.

The company operates a two-sided business model. On the franchise side, QC Kinetix licenses its brand, standardized clinical protocols, training, and national marketing to franchisee operators who run individual clinics under the QC Kinetix name, generating franchise fees and royalties. On the patient side, treatments are sold directly to consumers through free consultations and paid out-of-pocket, as regenerative medicine is generally not covered by insurance. Patient acquisition is driven by a multi-channel marketing approach spanning SEO/content marketing, social media, earned media, community programs (including the 'Pain Free for Heroes' military discount initiative), webinars, and the company's annual Charlotte medical conference. Ancillary sub-brands — QC Joint Health supplements and QC Pain Cream — extend the brand into consumer health products.

Leadership includes CEO Peter Holt (appointed April 2026, previously president and CEO of The Joint Corp. where he scaled the network from ~300 to nearly 1,000 clinics), National Medical Director Dr. Mitchell Sheinkop (board-certified orthopedic surgeon), and regional operators such as Richard Paz (President and CEO of QC Kinetix South Florida, overseeing 12 clinics). The company serves three core customer segments — adults with chronic joint pain (primary), athletes and active individuals, and U.S. veterans/active-duty military — and reports 46,000+ cumulative patient lives transformed.

Name

QC Kinetix

Legal name

QC Kinetix

Website

https://qckinetix.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

QC Kinetix is a Charlotte-based regenerative medicine franchise operating 100+ clinics across 30+ states, offering non-surgical orthobiologic treatments (PRP, BMAC, A2M/PPC, laser therapy) to patients with chronic joint pain, sports injuries, and musculoskeletal conditions on a cash-pay basis.

Ownership category

akta.pro rank

Product category

Regenerative Medicine Services

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Pain Management (Spine & Musculoskeletal) (HLAKALAM)

akta.pro secondary industry

Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ)

Keywords

• Regenerative medicine
• Orthobiologic treatments
• PRP therapy
• Non-surgical pain relief
• Joint pain treatment

Headquarters

HQ city

Charlotte

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Regenerative Medicine Treatment Services: QC Kinetix generates revenue through providing regenerative medicine treatments including PRP therapy, cellular therapy, BMAC, plasma protein concentrate, and Class IV laser therapy. Treatments are sold as one-time procedures or treatment protocols, typically paid out-of-pocket by patients as these services are generally not covered by insurance.
2. Franchise Fees: The company operates as a franchise system and generates revenue through franchise fees from individual clinic operators who pay for the right to use the QC Kinetix brand, protocols, and operational support.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels10 records

Core offering

QC Kinetix provides non-surgical regenerative medicine treatments for chronic joint pain, arthritis, sports injuries, and musculoskeletal conditions. Services are delivered through a network of 100+ franchised clinics across 30+ U.S. states and include PRP (Platelet-Rich Plasma) therapy, cellular therapy (BMAC), plasma protein concentrate (PPC/A2M), and Class IV laser therapy administered using the patient's own biologics.

Product overview

QC Kinetix operates as a regenerative medicine franchise offering a comprehensive suite of non-surgical, drug-free treatments for musculoskeletal pain and joint conditions. The core offering centers on orthobiologics treatments that utilize the patient's own biological materials to stimulate natural healing. The product portfolio includes: Cellular Therapy (using bone marrow-derived biologics), PRP Treatments (platelet-rich plasma), Class IV Laser Therapy, Plasma Protein Concentrate (PPC), and BMAC Treatment as primary treatment modalities. These are organized under treatment specialties including Regenerative Orthopedics and Regenerative Sports Medicine. The treatments work synergistically as part of a personalized multi-layered protocol: typically starting with plasma therapy, followed by A2M treatment, then BMAC, and finally PRP. The company operates over 100 clinic locations across 30+ states serving patients with chronic joint pain, sports injuries, and degenerative conditions as an alternative to surgery.

Differentiator

Problem solved

Functional benefit

Brands

• QC Joint Health: Joint and bone health supplement brand operated by QC Kinetix
• QC Pain Cream

Products and services

• PRP Treatments (Platelet-Rich Plasma)

Quantifiable outcome

• 46,000+ patient lives transformed
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators4 records

Recent moves7 records

Expansion highlights3 records

Broad incumbents

• Cleveland Clinic Regenerative Medicine: Cleveland Clinic's Center for Regenerative Medicine offers PRP and cellular therapies as part of a much broader hospital-system portfolio. Comparable treatment menu but with academic-medical-center credibility, insurance billing, and research backing that QC Kinetix lacks.
• Mayo Clinic Regenerative Medicine: Mayo Clinic's Regenerative Medicine program offers PRP and biologic therapies within a major hospital system. Comparable orthobiologics treatments but operating under an academic medical center with established research and reimbursement infrastructure.

Direct peers

• NovaGenix: NovaGenix is a regenerative medicine clinic group providing PRP, stem cell and hormone replacement therapies for joint pain and orthopedic conditions. Comparable cash-pay model, treatment menu, and consumer patient base.
• Atlas Health Medical Group: Atlas Health operates a multi-location regenerative medicine clinic network offering PRP, stem-cell and hormone therapies for chronic pain and orthopedic conditions. Direct comparable in cash-pay orthobiologics and patient demographic.
• Global Stem Cells Group: Global Stem Cells Group is an international regenerative medicine company operating clinics and training providers in stem-cell and PRP therapies. Comparable in treatment portfolio and cash-pay clinic operations targeting joint pain and orthopedic conditions.
• BioGenix: BioGenix operates a network of regenerative-medicine clinics offering PRP and cellular therapies for joint pain. Direct comparable in treatment modality, patient demographic, and cash-pay clinic model.
• Flexogenix: Flexogenix runs a multi-location clinic network providing non-surgical regenerative treatments for joint pain using PRP and other orthobiologics. Comparable in offering menu, patient demographic, and direct-to-consumer cash-pay model.
• Regenexx: Regenexx operates the largest direct competitor network in regenerative orthopedics, offering PRP and stem-cell-based treatments for musculoskeletal conditions through a clinic affiliate model. Most directly comparable in patient targeting, treatment menu, and cash-pay economics to QC Kinetix.

Emerging players

• Celling Biosciences: Celling Biosciences provides autologous point-of-care cell-therapy systems used by orthopedic and pain-medicine physicians. Comparable in orthobiologics focus, though positioned as a technology supplier to clinics rather than a consumer-facing franchise operator.

Others

• The Joint Corp. The Joint Corp. is the largest chiropractic franchise in the U.S. (the prior company of QC Kinetix's new CEO Peter Holt). Comparable as a franchise-system business model with similar unit-economics profile, marketing flywheel, and scaling playbook, although the underlying clinical service differs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/qckinetix

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about QC Kinetix